Tim is CDO at HotSpot Therapeutics. Previously, he spent over 18 years at Bristol Myers Squibb, most recently as a Senior Vice President within Research & Early Development and made key contributions to >120 INDs and >10 approved drugs. Tim currently serves as board director at Hookipa Pharma, industry representative to Cancer Research UK’s Experimental Cancer Medicines Centres, member of the Translation Research Council for CureSMA, and is co-founder and Chief Scientific Officer of the non-profit, Spinal Muscular Atrophy Research Team. He obtained his undergraduate degree from the University of Notre Dame, completed his doctoral training in Pharmaceutical Sciences from Wayne State University, and was a research fellow at the National Institutes of Health.